Pzena Investment Management LLC Grows Stock Position in Koninklijke Philips N.V. $PHG

Pzena Investment Management LLC lifted its stake in Koninklijke Philips N.V. (NYSE:PHG) by 33.5% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 20,978 shares of the technology company’s stock after buying an additional 5,267 shares during the period. Pzena Investment Management LLC’s holdings in Koninklijke Philips were worth $503,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of PHG. GAMMA Investing LLC grew its stake in shares of Koninklijke Philips by 25.8% in the first quarter. GAMMA Investing LLC now owns 13,789 shares of the technology company’s stock worth $350,000 after purchasing an additional 2,826 shares during the last quarter. SG Americas Securities LLC grew its stake in shares of Koninklijke Philips by 5.1% in the first quarter. SG Americas Securities LLC now owns 29,986 shares of the technology company’s stock worth $762,000 after purchasing an additional 1,463 shares during the last quarter. Wealth Enhancement Advisory Services LLC grew its stake in shares of Koninklijke Philips by 1.1% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 100,140 shares of the technology company’s stock worth $2,544,000 after purchasing an additional 1,137 shares during the last quarter. QRG Capital Management Inc. grew its stake in shares of Koninklijke Philips by 11.0% in the first quarter. QRG Capital Management Inc. now owns 142,595 shares of the technology company’s stock worth $3,622,000 after purchasing an additional 14,090 shares during the last quarter. Finally, Riverwater Partners LLC grew its stake in shares of Koninklijke Philips by 23.7% in the first quarter. Riverwater Partners LLC now owns 19,377 shares of the technology company’s stock worth $492,000 after purchasing an additional 3,716 shares during the last quarter. 13.67% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several analysts recently issued reports on PHG shares. Weiss Ratings reissued a “sell (d+)” rating on shares of Koninklijke Philips in a research note on Wednesday, October 8th. Wall Street Zen cut Koninklijke Philips from a “buy” rating to a “hold” rating in a research note on Saturday, August 2nd. One investment analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy”.

Koninklijke Philips Stock Performance

Koninklijke Philips stock opened at $27.53 on Tuesday. The stock’s 50 day simple moving average is $27.58 and its two-hundred day simple moving average is $25.27. Koninklijke Philips N.V. has a fifty-two week low of $21.48 and a fifty-two week high of $32.62. The stock has a market cap of $26.51 billion, a price-to-earnings ratio of 144.87, a PEG ratio of 0.72 and a beta of 0.82. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.81 and a current ratio of 1.26.

Koninklijke Philips (NYSE:PHG) last released its earnings results on Tuesday, July 29th. The technology company reported $0.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.29 by $0.12. Koninklijke Philips had a net margin of 1.00% and a return on equity of 11.95%. The firm had revenue of $5.05 billion during the quarter, compared to analyst estimates of $4.35 billion. As a group, analysts expect that Koninklijke Philips N.V. will post 1.63 earnings per share for the current fiscal year.

About Koninklijke Philips

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.